ID   RASL1_HUMAN             Reviewed;         804 AA.
AC   O95294; B7ZKM4; C9JFK5; F8VQX1; Q52M03; Q59H24; Q96CC7;
DT   04-MAY-2001, integrated into UniProtKB/Swiss-Prot.
DT   02-NOV-2010, sequence version 3.
DT   18-JUN-2025, entry version 196.
DE   RecName: Full=RasGAP-activating-like protein 1 {ECO:0000305};
DE   AltName: Full=RAS protein activator like 1 {ECO:0000312|HGNC:HGNC:9873};
DE   AltName: Full=Ras GTPase-activating-like protein {ECO:0000303|PubMed:9751798};
GN   Name=RASAL1 {ECO:0000312|HGNC:HGNC:9873};
GN   Synonyms=RASAL {ECO:0000303|PubMed:9751798};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANT HIS-321, PROBABLE FUNCTION,
RP   AND TISSUE SPECIFICITY.
RX   PubMed=9751798; DOI=10.1016/s0378-1119(98)00394-1;
RA   Allen M., Chu S., Brill S., Stotler C., Buckler A.;
RT   "Restricted tissue expression pattern of a novel human rasGAP-related gene
RT   and its murine ortholog.";
RL   Gene 218:17-25(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND VARIANT HIS-321.
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., Kovar-Smith C.,
RA   Lewis L.R., Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R.,
RA   Montgomery K.T., Morgan M.B., Nazareth L.V., Scott G., Sodergren E.,
RA   Song X.-Z., Steffen D., Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y.,
RA   Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G.,
RA   Chen Z., Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H.,
RA   Draper H., Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S.,
RA   Kelly S.H., Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M.,
RA   Nguyen B.-V., Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H.,
RA   Santibanez J., Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q.,
RA   Williams G.A., Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V.,
RA   Bailey M., Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E.,
RA   Burkett C.E., Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M., Dathorne S.R.,
RA   David R., Davis C.M., Davy-Carroll L., Deshazo D.R., Donlin J.E.,
RA   D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J., Escotto M., Flagg N.,
RA   Forbes L.D., Gabisi A.M., Garza M., Hamilton C., Henderson N.,
RA   Hernandez O., Hines S., Hogues M.E., Huang M., Idlebird D.G., Johnson R.,
RA   Jolivet A., Jones S., Kagan R., King L.M., Leal B., Lebow H., Lee S.,
RA   LeVan J.M., Lewis L.C., London P., Lorensuhewa L.M., Loulseged H.,
RA   Lovett D.A., Lucier A., Lucier R.L., Ma J., Madu R.C., Mapua P.,
RA   Martindale A.D., Martinez E., Massey E., Mawhiney S., Meador M.G.,
RA   Mendez S., Mercado C., Mercado I.C., Merritt C.E., Miner Z.L., Minja E.,
RA   Mitchell T., Mohabbat F., Mohabbat K., Montgomery B., Moore N., Morris S.,
RA   Munidasa M., Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O.,
RA   Nwokenkwo S., Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D., Trejos Z.Y.,
RA   Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I., Vera V.A.,
RA   Villasana D.M., Wang L., Ward-Moore S., Warren J.T., Wei X., White F.,
RA   Williamson A.L., Wleczyk R., Wooden H.S., Wooden S.H., Yen J., Yoon L.,
RA   Yoon V., Zorrilla S.E., Nelson D., Kucherlapati R., Weinstock G.,
RA   Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1/2/4), AND VARIANTS
RP   LEU-11; MET-58 AND HIS-321.
RC   TISSUE=Brain, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-700 (ISOFORM 4).
RC   TISSUE=Brain;
RX   PubMed=11230166; DOI=10.1101/gr.gr1547r;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H., Lauber J.,
RA   Duesterhoeft A., Beyer A., Koehrer K., Strack N., Mewes H.-W.,
RA   Ottenwaelder B., Obermaier B., Tampe J., Heubner D., Wambutt R., Korn B.,
RA   Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and analysis of
RT   500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [7]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=23999003; DOI=10.1016/j.jdermsci.2013.07.010;
RA   Yoo J.C., Lim T.Y., Park J.S., Hah Y.S., Park N., Hong S.G., Park J.Y.,
RA   Yoon T.J.;
RT   "SYT14L, especially its C2 domain, is involved in regulating melanocyte
RT   differentiation.";
RL   J. Dermatol. Sci. 72:246-251(2013).
CC   -!- FUNCTION: Probable inhibitory regulator of the Ras-cyclic AMP pathway
CC       (PubMed:9751798). Plays a role in dendrite formation by melanocytes
CC       (PubMed:23999003). {ECO:0000269|PubMed:23999003,
CC       ECO:0000269|PubMed:9751798}.
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Evidence={ECO:0000255|PROSITE-
CC         ProRule:PRU00041};
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=O95294-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O95294-2; Sequence=VSP_001627;
CC       Name=3;
CC         IsoId=O95294-3; Sequence=VSP_047005, VSP_047006;
CC       Name=4;
CC         IsoId=O95294-4; Sequence=VSP_047006;
CC   -!- TISSUE SPECIFICITY: Highly expressed in thyroid and adrenal medulla,
CC       lower expression in brain, spinal cord and trachea (PubMed:9751798).
CC       Expressed in melanocytes (PubMed:23999003).
CC       {ECO:0000269|PubMed:23999003, ECO:0000269|PubMed:9751798}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD92172.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF086713; AAD09006.1; -; mRNA.
DR   EMBL; AB208935; BAD92172.1; ALT_INIT; mRNA.
DR   EMBL; AC089999; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC014420; AAH14420.1; -; mRNA.
DR   EMBL; BC093724; AAH93724.1; -; mRNA.
DR   EMBL; BC143261; AAI43262.1; -; mRNA.
DR   EMBL; AL136672; CAB66607.2; -; Transcribed_RNA.
DR   CCDS; CCDS55888.1; -. [O95294-2]
DR   CCDS; CCDS55889.1; -. [O95294-3]
DR   CCDS; CCDS73529.1; -. [O95294-4]
DR   CCDS; CCDS9165.1; -. [O95294-1]
DR   RefSeq; NP_001180449.1; NM_001193520.2. [O95294-3]
DR   RefSeq; NP_001180450.1; NM_001193521.3. [O95294-2]
DR   RefSeq; NP_001288131.1; NM_001301202.2. [O95294-4]
DR   RefSeq; NP_001381010.1; NM_001394081.1. [O95294-3]
DR   RefSeq; NP_001381011.1; NM_001394082.1. [O95294-4]
DR   RefSeq; NP_001381012.1; NM_001394083.1. [O95294-4]
DR   RefSeq; NP_001381013.1; NM_001394084.1. [O95294-4]
DR   RefSeq; NP_001381014.1; NM_001394085.1. [O95294-1]
DR   RefSeq; NP_004649.2; NM_004658.3. [O95294-1]
DR   RefSeq; XP_005254007.1; XM_005253950.5. [O95294-3]
DR   RefSeq; XP_006719704.1; XM_006719641.4. [O95294-3]
DR   RefSeq; XP_011537154.1; XM_011538852.2.
DR   RefSeq; XP_011537155.1; XM_011538853.2.
DR   RefSeq; XP_016875517.1; XM_017020028.1.
DR   RefSeq; XP_047285632.1; XM_047429676.1. [O95294-3]
DR   AlphaFoldDB; O95294; -.
DR   SMR; O95294; -.
DR   BioGRID; 114017; 7.
DR   FunCoup; O95294; 551.
DR   IntAct; O95294; 1.
DR   STRING; 9606.ENSP00000450244; -.
DR   iPTMnet; O95294; -.
DR   PhosphoSitePlus; O95294; -.
DR   SwissPalm; O95294; -.
DR   BioMuta; RASAL1; -.
DR   jPOST; O95294; -.
DR   MassIVE; O95294; -.
DR   PaxDb; 9606-ENSP00000450244; -.
DR   PeptideAtlas; O95294; -.
DR   ProteomicsDB; 28360; -.
DR   ProteomicsDB; 50790; -. [O95294-1]
DR   ProteomicsDB; 50791; -. [O95294-2]
DR   Antibodypedia; 31222; 230 antibodies from 31 providers.
DR   DNASU; 8437; -.
DR   Ensembl; ENST00000261729.9; ENSP00000261729.5; ENSG00000111344.12. [O95294-1]
DR   Ensembl; ENST00000446861.7; ENSP00000395920.3; ENSG00000111344.12. [O95294-2]
DR   Ensembl; ENST00000546530.5; ENSP00000450244.1; ENSG00000111344.12. [O95294-3]
DR   Ensembl; ENST00000548055.2; ENSP00000448510.1; ENSG00000111344.12. [O95294-4]
DR   GeneID; 8437; -.
DR   KEGG; hsa:8437; -.
DR   MANE-Select; ENST00000548055.2; ENSP00000448510.1; NM_001301202.2; NP_001288131.1. [O95294-4]
DR   UCSC; uc001tul.4; human. [O95294-1]
DR   AGR; HGNC:9873; -.
DR   CTD; 8437; -.
DR   DisGeNET; 8437; -.
DR   GeneCards; RASAL1; -.
DR   HGNC; HGNC:9873; RASAL1.
DR   HPA; ENSG00000111344; Tissue enhanced (parathyroid gland, salivary gland).
DR   MalaCards; RASAL1; -.
DR   MIM; 604118; gene.
DR   neXtProt; NX_O95294; -.
DR   OpenTargets; ENSG00000111344; -.
DR   PharmGKB; PA34234; -.
DR   VEuPathDB; HostDB:ENSG00000111344; -.
DR   eggNOG; KOG2059; Eukaryota.
DR   GeneTree; ENSGT00940000158715; -.
DR   HOGENOM; CLU_008096_0_0_1; -.
DR   InParanoid; O95294; -.
DR   OMA; MEGACTD; -.
DR   OrthoDB; 1562946at2759; -.
DR   PAN-GO; O95294; 0 GO annotations based on evolutionary models.
DR   PhylomeDB; O95294; -.
DR   TreeFam; TF105302; -.
DR   PathwayCommons; O95294; -.
DR   Reactome; R-HSA-5658442; Regulation of RAS by GAPs.
DR   BioGRID-ORCS; 8437; 10 hits in 1136 CRISPR screens.
DR   CD-CODE; FB4E32DD; Presynaptic clusters and postsynaptic densities.
DR   ChiTaRS; RASAL1; human.
DR   GenomeRNAi; 8437; -.
DR   Pharos; O95294; Tbio.
DR   PRO; PR:O95294; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; O95294; protein.
DR   Bgee; ENSG00000111344; Expressed in lower esophagus mucosa and 140 other cell types or tissues.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005096; F:GTPase activator activity; TAS:ProtInc.
DR   GO; GO:0005543; F:phospholipid binding; TAS:ProtInc.
DR   GO; GO:0008270; F:zinc ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0071277; P:cellular response to calcium ion; IEA:InterPro.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:InterPro.
DR   GO; GO:0046580; P:negative regulation of Ras protein signal transduction; IEA:InterPro.
DR   GO; GO:1903861; P:positive regulation of dendrite extension; IDA:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   CDD; cd05135; RasGAP_RASAL; 1.
DR   FunFam; 1.10.506.10:FF:000020; Ras GTPase-activating protein 4 isoform 1; 1.
DR   FunFam; 2.30.29.30:FF:000283; Ras GTPase-activating protein 4 isoform 1; 1.
DR   FunFam; 2.60.40.150:FF:000150; RAS protein activator like 1; 1.
DR   Gene3D; 2.60.40.150; C2 domain; 2.
DR   Gene3D; 1.10.506.10; GTPase Activation - p120gap, domain 1; 1.
DR   Gene3D; 2.30.29.30; Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB); 1.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR035892; C2_domain_sf.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR039360; Ras_GTPase.
DR   InterPro; IPR037776; RASAL_RasGAP.
DR   InterPro; IPR023152; RasGAP_CS.
DR   InterPro; IPR001936; RasGAP_dom.
DR   InterPro; IPR008936; Rho_GTPase_activation_prot.
DR   InterPro; IPR001562; Znf_Btk_motif.
DR   PANTHER; PTHR10194; RAS GTPASE-ACTIVATING PROTEINS; 1.
DR   PANTHER; PTHR10194:SF3; RASGAP-ACTIVATING-LIKE PROTEIN 1; 1.
DR   Pfam; PF00779; BTK; 1.
DR   Pfam; PF00168; C2; 2.
DR   Pfam; PF00169; PH; 1.
DR   Pfam; PF00616; RasGAP; 1.
DR   SMART; SM00107; BTK; 1.
DR   SMART; SM00239; C2; 2.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00323; RasGAP; 1.
DR   SUPFAM; SSF49562; C2 domain (Calcium/lipid-binding domain, CaLB); 2.
DR   SUPFAM; SSF48350; GTPase activation domain, GAP; 1.
DR   SUPFAM; SSF50729; PH domain-like; 1.
DR   PROSITE; PS50004; C2; 2.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS00509; RAS_GTPASE_ACTIV_1; 1.
DR   PROSITE; PS50018; RAS_GTPASE_ACTIV_2; 1.
DR   PROSITE; PS51113; ZF_BTK; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Differentiation; GTPase activation;
KW   Metal-binding; Proteomics identification; Reference proteome; Repeat; Zinc;
KW   Zinc-finger.
FT   CHAIN           1..804
FT                   /note="RasGAP-activating-like protein 1"
FT                   /id="PRO_0000056645"
FT   DOMAIN          1..105
FT                   /note="C2 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   DOMAIN          116..231
FT                   /note="C2 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   DOMAIN          317..545
FT                   /note="Ras-GAP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00167"
FT   DOMAIN          565..672
FT                   /note="PH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   ZN_FING         674..710
FT                   /note="Btk-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00432"
FT   BINDING         21
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         21
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         27
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         74
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         74
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         76
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         76
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         82
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         149
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         149
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         155
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         202
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         202
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         204
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         204
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         210
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         682
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00432"
FT   BINDING         693
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00432"
FT   BINDING         694
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00432"
FT   BINDING         704
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00432"
FT   SITE            342
FT                   /note="Arginine finger; crucial for GTP hydrolysis by
FT                   stabilizing the transition state"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00167"
FT   VAR_SEQ         458
FT                   /note="Q -> QQ (in isoform 3)"
FT                   /evidence="ECO:0000303|Ref.2"
FT                   /id="VSP_047005"
FT   VAR_SEQ         552
FT                   /note="E -> EE (in isoform 3 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:11230166, ECO:0000303|Ref.2"
FT                   /id="VSP_047006"
FT   VAR_SEQ         610..637
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_001627"
FT   VARIANT         11
FT                   /note="V -> L (in dbSNP:rs7960087)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_031665"
FT   VARIANT         58
FT                   /note="T -> M (in dbSNP:rs34598602)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_031666"
FT   VARIANT         321
FT                   /note="R -> H (in dbSNP:rs1284879)"
FT                   /evidence="ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:9751798, ECO:0000269|Ref.2"
FT                   /id="VAR_031667"
FT   CONFLICT        141
FT                   /note="Q -> H (in Ref. 1; AAD09006)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        346
FT                   /note="L -> P (in Ref. 5; CAB66607)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        514
FT                   /note="Q -> R (in Ref. 5; CAB66607)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   804 AA;  90016 MW;  5D0065A093487FD0 CRC64;
     MAKSSSLNVR VVEGRALPAK DVSGSSDPYC LVKVDDEVVA RTATVWRSLG PFWGEEYTVH
     LPLDFHQLAF YVLDEDTVGH DDIIGKISLS REAITADPRG IDSWINLSRV DPDAEVQGEI
     CLSVQMLEDG QGRCLRCHVL QARDLAPRDI SGTSDPFARV FWGSQSLETS TIKKTRFPHW
     DEVLELREMP GAPSPLRVEL WDWDMVGKND FLGMVEFSPK TLQQKPPKGW FRLLPFPRAE
     EDSGGNLGAL RVKVRLIEDR VLPSQCYQPL MELLMESVQG PAEEDTASPL ALLEELTLGD
     CRQDLATKLV KLFLGRGLAG RFLDYLTRRE VARTMDPNTL FRSNSLASKS MEQFMKLVGM
     PYLHEVLKPV ISRVFEEKKY MELDPCKMDL GRTRRISFKG ALSEEQMRET SLGLLTGYLG
     PIVDAIVGSV GRCPPAMRLA FKQLHRRVEE RFPQAEHQDV KYLAISGFLF LRFFAPAILT
     PKLFDLRDQH ADPQTSRSLL LLAKAVQSIG NLGQQLGQGK ELWMAPLHPF LLQCVSRVRD
     FLDRLVDVDG DEAGVPARAL FPPSAIVREG YLLKRKEEPA GLATRFAFKK RYVWLSGETL
     SFSKSPEWQM CHSIPVSHIR AVERVDEGAF QLPHVMQVVT QDGTGALHTT YLQCKNVNEL
     NQWLSALRKA SAPNPNKLAA CHPGAFRSAR WTCCLQAERS AAGCSRTHSA VTLGDWSDPL
     DPDAEAQTVY RQLLLGRDQL RLKLLEDSNM DTTLEADTGA CPEVLARQRA ATARLLEVLA
     DLDRAHEEFQ QQERGKAALG PLGP
//
